Context. Palliative care continues to be a rapidly growing field aimed at improving quality of life for patients and their caregivers.
Introduction
Palliative care continues to be a rapidly growing field aimed at improving quality of life for patients with serious illness and their caregivers. Inpatient palliative care programs have increased their penetration by 85% from 2008 to 2015. 1 In 2015, 67% of hospitals with 50 or more beds in the U.S. reported having an interdisciplinary palliative care team, up from 53% in 2008. 2 Recent data showing a decrease in length of stay before a palliative care consult and an increase in hospital discharges after a palliative care consult indicate that patients are being referred to palliative care earlier and thus better able to maximize the benefit of these services. 3 A rapidly aging population with complex care needs, growing fiscal pressures, and increasing attention on value-based payment will likely accelerate emphasis on palliative care services in the U.S.
Concurrently, research in palliative care has significantly expanded. Several important and welldesigned studies have demonstrated that hospice and palliative services can improve patient and caregiver quality of life, satisfaction with care, and endof-life care communication and care planning, as well as reduce costs and unwanted care among a range of conditions and settings. 4e14 There is a growing body of research on the use and effectiveness of symptom management approaches, palliative care delivery models, and psychosocial, spiritual, and grief support services that can help to guide clinical practice and improve quality. As our understanding of what works in palliative and end-of-life care is growing, there is a need to usefully synthesize evidence across key areas about which interventions work, for whom, and under what conditions, to more directly guide clinical practice, quality measurement, and training/education, and to help make evidence-based policy decisions.
Clinical practice guidelines for palliative care provide a foundation for improving the quality and delivery of palliative care in the context of the rapid expansion of the field. The National Consensus Project (NCP) Clinical Practice Guidelines for Quality Palliative Care have played a critical role in advancing palliative care practice and providing guidance and support for providers. These guidelines informed the National Quality Forum palliative care framework endorsed in 2006 in addition to 38 preferred practices that provided a foundation for palliative care quality measurement and reporting. 15 The NCP Guidelines are consensus-based guidelines, informed by expert knowledge and current research. In response to an increasing need to develop evidencebased guidelines to inform policymakers, payors, and practitioners, the fourth edition of the guidelines will include and be informed by a robust systematic review of current evidence in palliative care. Palliative care clinical practice guidelines grounded in research evidence will help to ensure adoption and adherence by health care providers, health plans, accrediting agencies, and regulatory agencies and will assure they remain as the gold standard for informing practice and policy within the field.
We therefore undertook a systematic review of current evidence in palliative care to inform the fourth version of the NCP guidelines. In this study, we describe the review methods, key findings, and implications for the field.
Methods

Overview
This systematic review synthesizes the best current evidence for palliative care interventions across eight domains that structure the NCP clinical practice guidelines. The systematic review was supported by a technical expert panel. The review is registered in PROSPERO (CRD42018100065) and followed PRIS-MA guidelines. 16 Palliative care is defined as care, services, or programs with the primary intent of relieving suffering and improving health-related quality of life, including dimensions of physical, psychological/ emotional, social, and spiritual well-being. Ten key questions (KQs) were selected to guide the review (Supplemental File: Key Questions Search and Eligibility Criteria Table) .
Search Strategy
An experienced evidence-based practice center librarian designed and executed all searches. We searched the Cochrane Database of Systematic Reviews (health research), the database of systematic reviews by the Campbell Collaboration (health and social work research), PubMed (biomedical literature), PsycINFO (psychological literature), EMBASE (pharmacology research), CINAHL (nursing research), Academic Search Complete (social science and education), and the Web of Science (general science literature). We used search terms to reflect palliative, hospice, supportive, terminal, or end-oflife care for all KQs (Supplemental File: Search Strategy), combined with search terms relevant to each KQ. All searches were limited to Englishlanguage publications from 2013 (i.e., after the third edition of the NCP Guidelines was published) to February 2018. In addition, we reference-mined systematic reviews, used existing literature collections, and consulted with content experts.
Study Selection
To select studies for inclusion in the review, we applied eligibility criteria determined a priori following a PICOTSS (population, intervention, comparator, outcome, timing, setting, and study design) framework. Population: Eligible populations included patients of all ages with advanced illness and/or if relevant to the KQ, their family members and informal caregivers. Disease-specific (e.g., cancer, heart failure and other cardiac conditions, chronic pulmonary disease, dementia and other neurological conditions, liver disease, or renal disease) and nonspecific studies of advanced, late-or end-stage, or metastatic illness were eligible for inclusion. Identified reviews had to target patients with advanced, late-or end-stage, or metastatic illness and/or describe subgroup analyses of this population to be eligible for inclusion. Intervention: Studies had to report the effects of palliative care interventions on relevant patient and family/caregiver outcomes. Eligibility criteria for types of interventions varied by KQ (Supplemental File). Comparator: Studies had to include a comparator (usual care, waiting list, or other intervention) to be eligible but no other study design criterion for primary research was imposed. Outcome: Eligibility criteria for outcomes varied by KQ (Supplemental File). Timing: Studies could be of any duration and follow-up period. Setting: Reviews had to include studies conducted in U.S. settings to be eligible, although reviews could report on multiple geographic locations. All practice settings (e.g., inpatient, outpatient, home, community) were eligible. Study design: Systematic reviews were eligible for inclusion. Systematic reviews use a resource-intensive approach to identify relevant studies, searching multiple sources with comprehensive search strategies. The reviews appraise the risk of bias of individual studies and assess the study results independently from the original study authors. Systematic reviews often include a meta-analysis that aggregates data across studies to increase statistical power and to obtain an objective effect summary.
Screening Procedures
Experienced literature reviewers screened citations identified in the literature searches and trained a machine learning algorithm to identify relevant citations. One reviewer screened all citations; citations identified by the algorithm as potentially relevant were screened by two independent literature reviewers. Titles and abstracts deemed relevant by at least one reviewer were obtained as full-text publications to ensure that no relevant study was missed. Full-text publications were reviewed by two independent reviewers against the explicit eligibility criteria to minimize reviewer errors and bias. Discrepancies were resolved through discussion with the review team.
Data Abstraction and Critical Appraisal
From each included review, we abstracted review details (e.g., search dates, settings, number of included studies), participant characteristics, intervention descriptions, relevant results, and authors' conclusions. Where provided (e.g., meta-analyses), we abstracted pooled effect estimates. Data were abstracted in an online database for systematic reviews, using a pilottested form with detailed reviewer instructions to ensure standardized and accurate data extraction. Data were abstracted by one literature reviewer and checked for accuracy by an experienced second reviewer. Discrepancies were resolved by team discussion. We used an explicit and transparent approach to assess the methodological quality of included systematic reviews across 11 critical appraisal dimensions: 1) explicitly stated review questions; 2) appropriate inclusion criteria; 3) appropriate search strategy; 4) adequate sources and multiple databases searched; 5) appropriate appraisal criteria; 6) dual appraisal; 7) data abstraction process minimizing errors; 8) appropriate synthesis; 9) publication bias assessment; 10) recommendations supported by data; and 11) appropriate research suggestions. In addition, we considered context-specific criteria such as the applicability of the results to a palliative care review question.
Synthesis and Quality of Evidence Assessment
Evidence tables were created to allow a transparent and accessible overview and structure the available study details and results for all included studies. We summarized findings organized by KQ, intervention type, study population/age group (e.g., pediatric vs. adult), setting (e.g., inpatient vs. outpatient), and outcome in a Summary of Findings table. We assessed the quality of evidence using the Grading of Recommendations, Assessment, Development and Evaluations framework. The Grading of Recommendations, Assessment, Development and Evaluations framework 17 allows for a transparent overview using internationally accepted criteria to differentiate high, moderate, low, and very low quality of evidence to describe confidence in the findings among studies. We downgraded for study limitations (e.g., no randomized controlled trials contributing to the evidence), inconsistency in results across studies or lack of replication, imprecision (e.g., due to lack of reported effect estimates or imprecise estimates). We used the assessment of the systematic reviews evaluating the evidence base regarding indirectness, publication bias, or other criteria where applicable.
Results
Our search identified 3454 citations and we obtained 497 publications as full text (Fig. 1 ). We identified 139 systematic reviews meeting the inclusion criteria (18e156) and contributing to one or more KQ. All included reviews and their findings are documented in detail in an evidence table in Supplemental File. The methodological quality of the systematic reviews is summarized in a critical appraisal figure in Supplemental File. Key findings are summarized in Summary of Findings Tables 1e8. Domain 1: Structure and Processes of Care KQ 1a: What Is the Effect of Interdisciplinary Team Care on Patient Outcomes and Family/Caregiver Satisfaction With Care? Thirteen reviews met inclusion criteria for evaluating the effect of an interdisciplinary team on patient and family outcomes. There was moderatequality evidence for the impact of interdisciplinary teams on quality of life (Summary of Findings Table 1 ). Seven reviews reported on quality of life outcomes and consistently concluded that interdisciplinary care teams improved quality of life for patients with advanced illness. 18e20, 22, 23, 26, 27 A 2017 review noted growing support for the utilization of palliative care teams for improving quality of life in advanced illness (SMD 0.16; CI 0.01e0.31; six RCTs). 20 Another review found an association between the number of disciplines included on the interdisciplinary care team and improved quality of life. 26 Two reviews focused on cancer and heart failure patients also showed positive impacts. 23, 27 There was moderate-quality evidence for a positive impact of interdisciplinary teams on advance care planning (ACP) decisions, death at home, and patient and family satisfaction with care but lowquality evidence for a positive impact of interdisciplinary palliative care teams on patient physical symptoms and patient and family psychological Four reviews reported on ACP decisions using different measures but finding positive effects; including a Canadian HTA review that reported that a hospital teamebased model has been shown to increase the odds of completing ACPs compared to usual care (OR 1.6; no CI; low-moderate QoE). 19 One review concluded that review by specialist teams at the point of acute deterioration serves as a useful trigger for ACP decisions. Another review found that five of seven included studies examining palliative care team interventions for patients with heart failure showed increased documentation of preferences for care, advance directives, and DNR and end-of-life orders. One review found 12 pre-post studies demonstrating that palliative care team consultation was associated with code status changes and improved disease and prognosis awareness of patients. Four reviews examined the likelihood of dying at home and effects were positive. Two reviews found evidence that the use of a home teamebased model increased the odds of having a home death; the Canadian HTA estimated an 89% or more increase based on two RCTs (no CI). 19 Another review also identified a single RCT demonstrating that the use of an interdisciplinary palliative care team increased odds of having a home death. One review found that two of four included studies showed that palliative care team interventions were associated with an increase in death at home compared to in a hospital. 35 A second review concluded that early/ integrated palliative care may be slightly better than usual care at improving quality of life and another review reported mixed evidence on the impact of early/ integrated palliative care (no effect estimates). Several reviews addressed resource use but results varied across and within reviews and measures and only one review reported effect estimates (appropriate use of care SMD 0.37; CI 0.29, 0.45; six studies; utilization reduced SMD 0.22; CI À0.05, 0.49; four studies). 34 One review concluded that integrated palliative care can reduce hospitalizations. One review found that integrated care leads to reduced ED, hospital and acute care visits, and decreased hospital length of stay. Another review found that integrated care was associated with increased hospice referrals. However, two reviews found no difference between integrated and usual care in terms of health care use and hospital length of stay. outcomes. The quality of the evidence for the impact of teams on these outcomes was downgraded because of inconsistent conclusions and lack of pooled effect estimates. There was very low-quality evidence from two reviews of a positive impact of interdisciplinary team care in the ICU on mortality and family satisfaction with care, due to an absence of randomized controlled trials studying these outcomes, inconsistency in conclusions, and lack of pooled effect estimates. 24 Telehealth: There was moderate-quality evidence on a positive impact of telehealth for adults and children in the home/outpatient setting on psychological health (i.e., improvements in anxiety, depression, distress, PTSD; however, no effect estimates were provided), 39, 44, 46, 47 but low-to very low-quality evidence for all other outcomes including resource use, patient quality of life, physical symptoms, satisfaction with care, and family/caregiver quality of life, due to inconsistent findings, lack of pooled effect estimates, and study limitations described in included reviews.
Early/integrated care: There was low-quality evidence on the impact of early/integrated palliative care (i.e., palliative care provided early in the trajectory of an illness and/or integrated with standard treatment) on most patient outcomes including quality of life, physical symptoms, rehospitalization, patient satisfaction with care, and ACP, mainly due to individual study limitations and inconsistent findings. There was very low-quality evidence for early/ integrated palliative care on patient psychological health and mortality and family psychological health, satisfaction with care, and ACP.
Home-based care: There was high-quality evidence from two reviews for the impact of home-based palliative care on the likelihood of a patient dying at home. 31, 33 One review found that patients in homebased palliative care were more likely to die at home Summary of Findings Table 1 Continued 
The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text). One review found mixed evidence on the impact of pharmacological interventions for pain in pediatric populations. The review identified two RCTs where intrathecal baclofen was significantly associated with an improvement in pain among children with cerebral palsy, two RCTs where botulinum was not associated with improvements in pain in the same population, and three trials with mixed evidence on the positive impact of alendronate/risedronate for pain in osteogenesis imperfecta. The review did not report effect estimates.
Summary of Findings
L (Im, In)
Comprehensive palliative care Adults and mixed samples Outcome: symptom burden 1 SR 48 One review found that comprehensive palliative care was associated with a statistically and clinically significant reduction in symptom burden in adults with advanced illness at one-to three-month follow-up (SMD À0.66; CI À1.25, À0.07; 10 RCTs) and at four-to six-month followup (SMD À0.31; CI À0.05, À0.07; six RCTs; 48 There is limited evidence for the efficacy of metamizole in treating cancer pain. One review concluded that levomepromazine is completely or partially effective at managing pain. One review reported a lack of data to support a net conclusion but noted that methadone is a first-choice opioid for treating cancer pain. There is limited evidence as to the effect of using paracetamol and morphine to treat pain among people with dementia. Among adult patients with glioma, dexamethasone once a day is the preferred corticosteroid for pain control, though one review noted that nonsteroidal anti-inflammatory drugs (NSAIDS), analgesics, and coanalgesics should also be considered in the treatment of headache in patients with primary brain tumors. Among adult patients with metastatic bone pain, one review concluded that the use of bisphosphonates and denosumab for direct pain relief is weak. Similarly, another review concluded that there is no or very low-quality evidence to support the use of adjuvant analgesics in patients with metastatic bone pain. None of the reviews reported effect estimates. À0.50, À0.05; P ¼ 0.02; 11 studies). 67 Another review found evidence for opioids for improving breathlessness among patients with advanced cancer. One review reported evidence that some opioids are effective at treating dyspnea in advanced cancer patients and that benzodiazepines showed no significant benefit at treating dyspnea. One review concluded there is evidence from weak study designs for improvements in dyspnea after administration of diamorphine. Another review reported potential benefits for using nebulized furosemide, hydromorphone, and fentanyl to treat dyspnea, but mixed evidence for nebulized morphine. Pharmacological interventions Adults and mixed samples Outcome: constipation 2 SRs 92, 95 Two reviews reported constipation-related outcomes of pharmacological interventions but did not report effect estimates and found mixed evidence. One review found several RCTs supporting the use of dietetic interventions with probiotics and prebiotics for relieving symptoms of constipation, and mixed evidence supporting the use of lubiprostone, macrogol, and injections of botulinum neurotoxin A for outlet obstruction constipation. Another review found six RCTs and concluded that evidence supporting the use of laxatives such as lactulose and senna for management of constipation was uncertain but that subcutaneous methylnaltrexone is effective in inducing laxation in palliative care patients with opioid-induced constipation. Twelve reviews reported pain management outcomes related to radiation and/or chemotherapy intervention; effects varied by study and outcome. One review concluded that palliative RT was effective at improving pain and that low regimens appear to be adequate for symptom palliation. Two reviews concluded that singlefraction and multifraction schedules held equivalent effectiveness for pain relief, while another review found greater use of shorter or single-fraction regimens may be beneficial, especially in patients with poor performance status. One review concluded that there was no difference in pain response across multiple fraction radiotherapy doses. One review concluded there was no significant difference in palliation of chest pain between higher and lower RT doses (combined OR 1.83; CI 0.76, 4.38; P ¼ 0.176; three RCTs). 79 One review found that 10 and 6 Gy may produce superior pain response compared to 8 Gy, and 6 Gy may result in better partial response than 8 Gy, but noted that only a few studies documented doses other than 8 Gy. Similarly, another review concluded that 8 Gy should be the standard dose against which future treatments are compared due to its reproducible pain response rate and its established safe profile. Another review concluded that the efficacy of reirradiation is comparable to initial radiation treatment. One review concluded that palliative pelvic RT was effective at relieving pain in rectal cancer (pooled positive response across 23 studies: 78%) but noted there is considerable heterogeneity in treatments and outcomes across studies. 82 One review found positive impact of radionuclides on pain relief. Three reviews reported pain management outcomes related to music/art therapies and all reported positive effects on pain management, while acknowledging differences across studies in control groups and pain assessment tools. One review found that exposure to creative arts and music therapies is shown to reduce pain postintervention compared to no treatment, waiting list, usual care, or placebo controls (SMD 0.54; CI 0.33, 0.75; 18 RCTs) and at follow-up (SMD 0.59; CI 0.41, 0.77; seven RCTs). 94 Another review found that music therapy was associated with a significant reduction in pain compared to comfort measures, a volunteer visit, or standard care only but noted a high risk of bias among included studies (SMD À0.42; CI À0.68, À0.17; three non-RCT studies). 69 Table 2 ).
Summary of Findings
Music/art therapy: However, there was moderatequality evidence from three reviews 51,69,94 demonstrating the positive impact of music/art therapy on Summary of Findings Table 2 Continued V (Im, In) N ¼ number of systematic reviews; RT ¼ radiotherapy; SR ¼ systematic review; RCT(s) ¼ randomized controlled trial(s); L ¼ low quality of evidence; Im ¼ imprecision; In ¼ inconsistency; SMD ¼ standardized mean difference; M ¼ moderate quality of evidence; S ¼ study limitation; MD ¼ mean difference; V ¼ very low quality of evidence; OR ¼ odds ratio. a The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text). Five systematic reviews reported depression outcomes related to psychospiritual interventions and found mixed evidence. One review reported evidence that life review interventions can improve depressive symptoms (SMD À0.78; CI À1.46, À0.11; five RCTs) but noted considerable heterogeneity across studies. 107 One review found mixed evidence on the effects of dignity therapy on depression and concluded that effects of dignity therapy on depression are still controversial, requiring further evidence on greater impact. Similarly, another review also concluded that additional research is needed to determine the efficacy of dignity therapy. One review identified a single nonrandomized study reporting decreases in depression after a manualized psychospiritual therapy intervention. Three reviews reported anxiety outcomes for music/art therapies. One review reported that creative art therapies significantly reduced anxiety compared to controls (SMD 0.28; CI 0.11e0.44; 25 RCTs) after intervention. 94 Another review found four studies (one RCT and three pre-post) demonstrating positive effects of music therapy on anxiety. Finally, a third review found two studies examining the effect of music therapy; both found significant reductions in anxiety associated with the intervention.
M (Im)
Music/art therapy Adults Outcome: depression 2 SRs 51,94 Two reviews reported depression outcomes for music/ art therapies and the effects were positive. One review reported that creative arts therapies significantly reduced depression compared to no treatment, waiting list, usual care, or placebo controls (SMD 0.23; CI 0.05, 0.40; 11 RCTs) after intervention. 94 Another review found three studies (one RCT and two pre-post) demonstrating mixed effects of music therapy on depression.
M (In)
Information and communication tools (telehealth, web sites) Adults and mixed samples Outcome: emotional well-being 1 SR 72 One review found one pre-post study showing videoconferencing significantly improved anxiety for patients at rural health care sites, and one RCT showing that palliative care telephone support significantly improved mood and emotional bother but did not report effect estimates. The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text).
pain management outcomes; one review found that exposure to creative arts and music therapies is shown to reduce pain postintervention (SMD 0.54; CI 0.33e0.75; 18 RCTs) and at follow-up (SMD 0.59; CI 0.41e0.77; seven RCTs). 94 Another review found that music therapy was associated with a significant reduction in pain (SMD À0.42; CI À0.68, À0.17; three non-RCT studies). 69 Comprehensive palliative care: There was also moderate-quality evidence for the impact of a comprehensive palliative care team for adults on symptom burden. One review found that comprehensive palliative care was associated with a statistically and clinically significant reduction in symptom burden in adults with advanced illness at 1-to 3-month follow-up (SMD À0.66; CI À1.25, À0.07; 10 RCTs) and at 4-to 6-month follow-up (SMD À0.31; CI À0.05, À0.07; six RCTs. 48 Pharmacotherapies: Fifteen reviews were found synthesizing evidence on pharmacological interventions for pain, dyspnea, nausea/vomiting, and constipation, but evidence was low-to very low-quality, due to inconsistent findings across studies and a lack of pooled effect estimates. Eight reviews addressed pharmacological interventions for pain management and concluded there is limited evidence for metamizole in cancer pain, 70 methadone as a first-choice opioid for cancer pain, 76 levomepromazine for pain among palliative care patients, 89 paracetamol and morphine for pain in dementia patients, 65 and the use of bisphosphonates 68 or adjuvant analgesics 66 for relief of metastatic bone pain. One review concluded that transdermal buprenorphine and transdermal fentanyl demonstrate equivalent analgesic efficacy in patients with cancer pain but noted that long-term data are lacking, 56 and another review concluded that once-aday dexamethasone is the preferred corticosteroid for pain control among adult patients with glioma. 60 Three reviews reported dyspnea outcomes of pharmacological interventions; a 2016 Cochrane review concluded that there is some low-quality evidence demonstrating the ability for oral or parenteral opioids to palliate breathlessness although the number of included participants was small (change from baseline SMD À0.09; CI À0.36, 0.19; P ¼ 0.54; seven studies; post-treatment SMD À0.28; CI À0.50, À0.05; P ¼ 0.02; 11 studies). 67 Evidence for pharmacological interventions for nausea and vomiting was of very low quality. A 2017 Cochrane review found very low-quality evidence that neither supported nor refuted corticosteroid use for nausea/vomiting among patients with advanced cancer (SMD 0.48; CI À1.53, 0.57; two RCTs). 59 Another review 89 concluded that levomepromazine is completely or partially effective at managing nausea/vomiting. Two reviews 73, 86 concluded that there is insufficient direct evidence to definitively support the use of haloperidol for the management of nausea and vomiting.
Two reviews reported constipation-related outcomes of pharmacological interventions but did not report effect estimates and found mixed evidence. One review found several RCTs supporting the use of dietetic interventions with probiotics and prebiotics for relieving symptoms of constipation, and mixed evidence supporting the use of lubiprostone, macrogol, and injections of botulinum neurotoxin A for outlet obstruction constipation. 92 Another review found six RCTs and concluded that evidence supporting the use of laxatives such as lactulose and senna for management of constipation was uncertain but that subcutaneous methylnaltrexone is effective in inducing laxation in palliative care patients with opioid-induced constipation. 95 Cannabinoids: Evidence for the impact of cannabinoids on pain and nausea/vomiting was also of low quality primarily due to the limited number of trials contributing to the evidence, and inconsistent findings among those trials. 52 Evidence for nonpharmacological physical interventions (e.g., oxygen, cool air) Table 4 Social Aspects of Care 110 One review found that various caregiver support services helped to identify caregivers' direct support service needs, decreased caregiver role overload, and led to a nonsignificant increase in social support and benefits finding; however, the review reported no effect estimate across studies.
Summary of Findings
L (Im)
Social support Adults Outcome: social support 1 SR 106 One review reported findings from a single RCT of group therapy for patients with life-limiting illness that showed no demonstrable difference in social support; the review did not report effect estimates.
V (Im, In)
N ¼ number of systematic reviews; NA ¼ not applicable; SR ¼ systematic review; L ¼ low quality of evidence; Im ¼ imprecision; RCT(s) ¼ randomized controlled trial(s); V ¼ very low quality of evidence; In ¼ inconsistency. a The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text). 98 but noted a high degree of heterogeneity. Another review also found that life review was associated with improvements in spiritual well-being. One review described evidence that dignity therapy was associated with decreased existential distress, enhanced interpersonal and transpersonal spirituality, and improved spiritual well-being. Another review also found that dignity therapy was associated with higher levels of spiritual well-being. A fifth review found that life review was associated with improved spiritual well-being and existential distress but that dignity therapy was not associated with significant improvement in existential domains.
Summary of Findings
M (In)
Life Table 3 ). Three reviews reported anxiety outcomes for music/art therapies. 51, 69, 94 One review reported that creative art therapies significantly reduced anxiety (SMD 0.28; CI 0.11e0.44; 25 RCTs) and depression (SMD 0.23; CI 0.05e0.40; 11 RCTs) compared to controls after intervention. 94 Another review found four studies (one RCTand three pre-post) demonstrating positive effects of music therapy on anxiety and three studies (one RCT and two pre-post) demonstrating reduced depression. 51 A third review found two studies demonstrating significant reductions in anxiety associated with music therapy. 51 There was moderate-quality evidence that cannabinoids did not have an impact on depression compared to placebo 52 and very low-quality evidence indicating that nonpharmacological cognitive interventions such as relaxation, imagery, hypnosis, psychosocial interventions, and psychospiritual interventions can improve depressive symptoms. One review identified a single RCT of a multimodal psychosocial intervention demonstrating clinically significant benefit on depressive symptoms. 60 There was also very lowquality evidence on the impact of education interventions and exercise interventions on depression and anxiety. 57, 81 Domain 4: Social Aspects of Care KQ 4: Does an Assessment of Environmental or Social Needs as Part of a Comprehensive Palliative Assessment Improve Needs Identification and Access to Relevant Services? Two reviews met inclusion criteria for evaluating an assessment of environmental or social needs as part of a comprehensive palliative assessment (Summary of Findings Table 4 ). 106, 110 There is low-quality evidence that social work interventions lead to the identification of and access to social services. One review found that various caregiver support services helped to identify caregivers' direct support service needs, decreased caregiver role overload, and led to a nonsignificant increase in social support and benefits finding; however, the review reported no effect estimate across studies. 110 There is very low-quality evidence that social support interventions do not impact social support outcomes. A review reported findings from a single RCT of group therapy for patients with life-limiting illness that showed no demonstrable difference in social support; the review did not report effect estimates. 106 Domain 5: Spiritual, Religious, and Existential Aspects of Care The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text).
caregiver spiritual and emotional well-being (Summary of Findings Table 5 ). Life review/dignity therapy: There is moderatequality evidence for the positive impact of life review/dignity therapy on spiritual well-being. A 2017 review reported beneficial effects of life review on spiritual well-being (SMD 0.33; CI 0.12e0.53; four RCTs) but noted a high degree of heterogeneity. 98 Another review also reported that life review was associated with improvements in spiritual well-being. 113 One review described evidence that dignity therapy was associated with decreased existential distress, enhanced interpersonal and transpersonal spirituality, and improved spiritual well-being. 100 Another review reported that dignity therapy was associated with higher levels of spiritual well-being. 103 A fifth review reported that life review was associated with improved spiritual well-being and existential distress but that dignity therapy was not associated with significant improvement in existential domains. 97 There was low to very low evidence for life review/ dignity therapy's impact on other outcomes such as meaning and purpose, will to live, acceptance of death, and emotional well-being.
Other spiritual interventions: There is very low evidence for a positive impact of spiritual/religious interventions on spiritual well-being. There was also very low-quality evidence for a positive impact of other meaning-centered interventions on spiritual wellbeing, emotional well-being, meaning and purpose, quality of life, and will to live. Domain 6: Cultural Aspects of Care KQ 6: What Is the Impact of Culturally and Linguistically Sensitive Care on Physical, Social, Emotional, and Spiritual Well-being of the Patient and Family/Caregiver? Three reviews met inclusion criteria for evaluating the impact of culturally and linguistically sensitive care on physical, social, emotional, and spiritual well-being of the patient and family/caregiver (Summary of Findings Table 6 ). Evidence is of very low-quality, owing to study limitations, inconsistency in findings, and lack of pooled effect estimates in the three identified reviews. There was very low-quality evidence that culturally relevant palliative care led to higher rates of do-notresuscitate orders and improved quality of death from both the patient and family/caregiver perspectives. One review found one study of a culturally tailored inpatient palliative care consultation services reporting a postintervention increase in do-notresuscitate completion among Native American patients but did not report effect estimates. 115 Another Summary of Findings Table 6 Cultural Aspects of Care 116 One review found a single pilot study reporting significant increases in coping skills and in self-efficacy among caregivers but did not report effect estimates.
V (S, Im, In)
Interpreters Adults and mixed samples Family/caregiver outcome: information sharing 1 SR 116 One review concluded that improving access to and/or standardizing utilization of professional interpreter services could improve the quality of care provided to patients at the end of life but did not report effect estimates.
N ¼ number of systematic reviews; NA ¼ not applicable; SR ¼ systematic review; DNR ¼ do-not-resuscitate; V ¼ very low quality of evidence; S ¼ study limitation;
The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text). Grief/bereavement support services Pediatric Child outcome: grief 2 SRs 120,121 Two reviews reported pediatric grief outcomes and found positive effects. One review identified five studies with strong evidence on medium to large effects of grief and bereavement support on parentally bereaved children's traumatic grief symptoms. Another review found some evidence that bereavement services for bereaved child siblings contributed positively to the grief experience. Neither review reported effect estimates across studies.
Summary of Findings
M (Im)
Grief/bereavement support services Pediatric Child outcome: emotional well-being 2 SRs 120,121 Two reviews reported pediatric emotional well-being outcomes and found mixed evidence. One review identified some studies with strong evidence on small effects for parentally bereaved children's PTSD symptoms (one study), anxiety (two studies), and depression in girls (one study); one study identified in the same review did not show effects for boys on the anxiety and depression. Another review identified one study demonstrating a positive effect of group-based grief/ bereavement services on bereaved child siblings' sense of isolation, development of healing friendships, and coping skills. Neither review reported effect estimates across studies.
L (Im, In)
Grief/bereavement support services Pediatric Adult family outcome: grief 2 SRs 120,121 Two reviews reported bereaved parent grief outcomes and found mixed evidence. One review identified two studies with strong evidence on medium effects for grief discussions in the family; another study with strong evidence identified in the same review showed no effects of grief/bereavement services on bereaved parents' present grief. Another review found mixed evidence on the positive impact of grief/bereavement services for bereaved parents and concluded that bereavement services are most effective for parents experiencing more complex mourning. Neither review reported effect estimates.
Grief/bereavement support services Pediatric Adult family outcome: emotional well-being 2 SRs 120,121 Two reviews reported emotional well-being outcomes related to parental grief/bereavement support interventions and found conflicting evidence. One review found evidence on the impact of grief/bereavement services on bereaved parents' feelings of being supported; parental depression; and mental health. However, two studies identified in the same review with strong evidence showed no effects on depression.
Another review found qualitative evidence on improvements in bereaved parents' emotional status after a group-based grief/bereavement support group. Neither review reported effect estimates.
Grief/bereavement support services Adults Adult family outcome: grief 1 SR 122 One review found that bereaved caregivers participating in predeath grief interventions had more favorable postdeath emotional health outcomes, including lower levels of grief, but did not report effect estimates.
L (Im)
Grief/bereavement support services Adults Adult family outcome: emotional well-being 2 SRs 117,122 Two reviews reported family emotional well-being outcomes and found positive effects but neither reported effect estimates. One review identified a single RCT of family group therapy that demonstrated reductions in distress and depressive symptoms among informal caregivers for cancer patients. Another review found evidence showing that receiving affective support both before and after family members' death mediates negative bereavement outcomes such as depressive symptoms, anxiety, and guilt in bereaved caregivers.
Grief counseling/therapy Adults Adult family outcome: grief 2 SRs 118,119 Two reviews reported grief outcomes related to grief counseling/therapy interventions and found mixed evidence on impact but neither reported effect estimates. In one review, complicated grief therapy was found to be more effective than interpersonal psychotherapy in reducing abnormal grief. Another review found that grief management and counseling interventions did not have a significant impact on caregiver anticipatory grief but did find a single RCT demonstrating small improvements in postdeath and complicated grief outcomes after a multicomponent grief counseling intervention.
V (S, Im, In) (Continued) review found that a single pilot study reported significant increases in coping skills among patients and family/caregivers and decreases in depressive symptoms among patients but did not report effect estimates. 117 There was also very low-quality evidence that interpreters have a positive impact on quality of care, communication, and information sharing. Table 7 ). Two reviews reported pediatric grief outcomes. 120, 121 One review identified five studies with strong evidence on medium to large effects of grief and bereavement support on parentally bereaved children's traumatic grief symptoms. 121 Another review found some evidence that bereavement services for bereaved child siblings contributed positively to the grief experience. 120 Neither review reported effect estimates across studies. There is lowquality evidence for these interventions on pediatric emotional well-being and adult grief and well-being outcomes due to imprecision and inconsistency of results. There is low-quality evidence for grief and bereavement support services on grief and emotional well-being outcomes among bereaved adult caregivers. 117, 122 There was also very low-quality evidence on the impact of grief counseling and therapy interventions on bereaved adult grief and emotional wellbeing outcomes. Results varied by type and style of counseling intervention and the specific outcomes measured; for example, complicated grief versus anticipatory grief. 118 In one review, complicated grief therapy was found to be more effective than interpersonal psychotherapy in improving work and social adjustment; however, the review did not report effect estimates.
V (S, Im)
End-of-life care Pediatric
End-of-life caredpharmacological sedation Adults Outcome: quality of care 1 SR 124 One review found four nonrandomized studies comparing sedated and nonsedated groups and showed that despite sedation with the intent to control symptoms, delirium and dyspnea were still troublesome symptoms in these people in the last few days of life and were significantly worse in the sedated group. Control of other symptoms appeared to be similar in sedated and nonsedated groups. In addition, all studies identified in the review except one compared survival time in the sedated and nonsedated groups and concluded that there was no statistically significant difference between the groups. The review did not report effect estimates.
End-of-life caredpharmacological symptom control Adults Outcome: quality of care 1 SR 123 One review examining a range of palliative interventions and outcomes concluded that there is a lack of evidence concerning the effectiveness and safety of palliative drug treatment in dying patients. No evidence was found for scopolamine hydrobromide and atropine for death rattle; some evidence was found supporting the use of morphine and midazolam for dyspnea, anxiety, or terminal restlessness; and some support was found for morphine, diamorphine, and fentanyl for pain. The review did not report effect estimates.
V (Im, In)
N ¼ number of systematic reviews; SR ¼ systematic review; M ¼ moderate quality of evidence; Im ¼ imprecision; PTSD ¼ post-traumatic stress disorder; L ¼ low quality of evidence; In ¼ inconsistency; RCT(s) ¼ randomized controlled trial(s); V ¼ very low quality of evidence; S ¼ study limitation; NA ¼ not applicable.
a
The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text). Two reviews concluded that family-centered ACP increases the likelihood of limiting the use of futile or expensive and invasive treatments at the end of life but did not report effect estimates.
Summary of Findings
L (S, Im)
Family-centered ACP Pediatric Multiple settings Outcome: decisional conflict 1 SR 151 One review identified a single RCT that reported that family-centered ACP leads to decreased decisional conflict.
V (Im, In)
Family-centered ACP Pediatric Multiple settings Outcome: preference-concordant care 1 SR 141 One review identified a single longitudinal cohort study reporting that family-centered ACP for children and adolescents with cancer increased the likelihood that patients were more likely to receive end-of-life care that was consistent with their preferences.
V (S, Im, In)
Family-centered ACP Pediatric Multiple settings Outcome: surrogate understanding 2 SRs 141,151 Two reviews reported surrogate understanding of the outcomes and found positive effects but did not provide effect estimates. One review identified a longitudinal cohort study reporting that family-centered ACP for children and adolescents with cancer increased family's ability to honor the wishes of their children. Another review identified one RCT of a family-centered ACP intervention for children or adolescents with HIV that found the intervention increased congruence in adolescent/surrogate treatment preferences. Four reviews reported treatment decision outcomes related to the use of decision tools and found mixed evidence. One review reported low-quality evidence that patients receiving video decision tool interventions are less likely to prefer CPR than controls (RR 0.50; CI 0.27, 0.95; seven RCTs) but noted low-quality evidence due to considerable heterogeneity across studies. 145 Three other reviews found that video decision tools were associated with significant increases in the selection of comfort care as primary goal, but none reported effect estimates. Three reviews reported on the impact of decision tools on documentation but found mixed evidence. One review concluded that there may be a small effect of decision aids on documentation of advance directives but with a wide CI including no effect (RR 1. 145 In another review, four studies were identified showing increased rates of ACP documentation, but two studies showed no change. Another review also found mixed evidence on the positive impact of decision aids on ACP documentation. Decision tools Adults or mixed samples Multiple settings Outcome: quality of communication 2 SRs 72, 146 Two reviews reported communication outcomes and found mixed evidence, but effect estimates were not reported. One review described three decision tools that were found to improve clinical communication. Another review found two studies demonstrating the positive effect of decision aids on quality and frequency of end-oflife communication, and one study where no change was detected.
L (Im, In)
Decision tools Adults or mixed samples Multiple settings Outcome: decisional conflict/consensus 5 SRs 72, 134, 135, 145, 146 Five reviews reported decisional conflict outcomes and found mixed evidence on impact. None of the reviews reported effect estimates. One review found three studies reporting improved decisional conflict associated with multicomponent decision aid interventions. Another review reported a single RCT of a video decision aid that led to increased certainty about decision making. One review reported improvements in decisional conflict in eight studies but the reduction was only significant in four studies. Another review reported a single RCT reporting significantly lower decisional uncertainty associated with a video decision aid than control. Another review reported a single high-quality RCT that found no change in decisional conflict associated with a decision aid intervention. 150 One review noted that patients who had care planning discussions with a single provider were less likely to be resuscitated (two observational studies) and more likely to receive hospice care (one RCT) than those who did not participate in care planning discussions. Two reviews examined the impact of facilitated ACP on documentation of ACP and reported mixed evidence. One review concluded on the basis of one RCT and seven non-RCT studies that a low level of evidence indicates that facilitated ACP models increase documentation of advance directives and physician orders; another review highlighted the lack of consistent patient outcome evidence to support the use of facilitated ACP models to improve documentation. The GRADE category is based on identified systematic reviews published between 2013 and February 2018. We used the following reasons for downgrading confidence in the evidence (downgraded by 1 or 2): Study limitation (observational studies start with a low GRADE value), Inconsistency (individual studies do not come to the same conclusions or there is only one study so inconsistency cannot be evaluated), Imprecision (there is no effect estimate, there is no measure of dispersion, or the CI is very broad); we used the systematic review authors' evaluation for other GRADE criteria if there was a formal quality of evidence assessment (see text).
Summary of Findings
there was lower quality of care in patients receiving pharmacological sedation compared to nonsedated groups. One review found four nonrandomized studies comparing sedated and nonsedated groups and showed that despite sedation with the intent to control symptoms, delirium and dyspnea were still troublesome symptoms in these people in the last few days of life and were significantly worse in the sedated group. Control of other symptoms appeared to be similar in sedated and nonsedated groups. In addition, all studies identified in the review except one compared survival time in the sedated and nonsedated groups and concluded that there was no statistically significant difference between the groups. The review did not report effect estimates. 124 There was also very low-quality evidence supporting specific treatments for pharmacological symptom control at the end of life. One review examining a range of palliative interventions and outcomes concluded that there is a lack of evidence concerning the effectiveness and safety of palliative drug treatment in dying patients.
No evidence was found for scopolamine hydrobromide and atropine for death rattle, some evidence was found supporting the use of morphine and midazolam for dyspnea, anxiety, or terminal restlessness, and some support was found for morphine, diamorphine, and fentanyl for pain. The review did not report effect estimates. 123 129 and moderate-quality evidence regarding the impact of ethics consultation on treatment decisions. 129, 153 One review found that ethics consultation was associated with nonsignificant decreased use of mechanical ventilation (À3.18 d; CI e8.27, 1.90; P ¼ 0.22, three RCTs) and artificial nutrition and hydration (À0.79 d; CI, À2.98, 1.41; P ¼ 0.48). 129 Another review found decreased use of mechanical ventilation associated with ethics consultation in one RCT. 153 Advance directives: There is moderate-quality evidence from three reviews that advance directive interventions lead to preference-concordant care (i.e., care provided consistent with expressed preferences) and to increased preference documentation. 125, 127, 148 One review found that patients receiving advance directive interventions with communication had a significantly increased likelihood of receiving end-oflife care in concordance with their preferences compared with control groups (OR 4.66; CI 1.20, 18.08; three RCTs). 125 This review also showed an increased likelihood for the completion of advance directives compared to usual care (OR 3.26; CI 2.00, 5.32; 13 RCTs). 125 However there is low-to very lowquality evidence for advance directive interventions among pediatric populations, due to individual study limitations and lack of effect estimates and inconsistent findings. 152 Care planning discussions: There is also moderatequality evidence synthesized in a 2014 Health Quality Ontario systematic review for the positive impact of care planning discussions on preference concordant care, concordance between patient and family wishes, and documentation of ACP processes and documents. 150 There is low-quality evidence for ACP decision aids. Mixed evidence suggests that decision aids may lead to lower intensity treatment decisions (RR 0.50; CI 0.27, 0.95; seven RCTs) but heterogeneity across studies tempers confidence in the evidence base. 145 One review concluded that there may be a small effect of decision aids on documentation of advance directives but with a wide CI including no effect estimate (RR 1.1; CI 0.85e1.46; four RCTs). There was inconsistency in findings related to the impact of decision aids on quality of communication, decisional conflict or consensus, concordance, and caregiver well-being, and no pooled effect estimates were reported. 72, 134, 135, 145, 146 Family meetings: There is low-quality evidence for family meetings improving caregiver well-being. One review found evidence, including from a single multicenter RCT, that structured family meetings could improve psychological well-being and decrease posttraumatic stress symptoms in bereavement. 154 
Quality Assessment
The methodological quality of the included systematic reviews varied considerably. Most reviews stated explicit review questions, searched adequate sources, conducted an appropriate synthesis of the evidence, and made appropriate research suggestions (Supplemental File: Critical Appraisal Figure) .
Discussion
This systematic review identified 139 systematic reviews addressing key research questions across the eight palliative care domains specified in the NCP Clinical Practice Guidelines, reflecting the growth in palliative care research over the past five years. Despite the major undertaking these reviews represent, much of the evidence for palliative care remains with low-quality, due to inconsistency in study findings, the lack of precise effect estimates to support the effectiveness of interventions, and large variation in study designs, with few RCTs that allow strong evidence statements contributing to the evidence base.
Palliative care is a relatively new specialty, with board certification by the American Board of Internal Medicine being offered for the first time in 2008. As palliative care as a specialty has matured over the last decade, so has the evidence supporting its practice. We identified 48 systematic reviews addressing palliative care interventions for physical symptoms, 36 reviews examining ACP interventions, and 26 reviews covering psychological/psychiatric management in palliative care, all published in the last five years. While it is impressive that as much research as exists is available to inform palliative care practice, more targeted efforts at strategically building the evidence base to conduct well-designed studies and provide high-quality support for specific palliative care interventions are needed. Moreover, despite the challenges of conducting RCTs in some areas of palliative care, 157 greater attention to the opportunities to do so combined with the use of other robust study designs examining key outcomes will increase the quality of the evidence.
We found high-quality evidence in only one area: the impact of home-based palliative care on home death. Home-based palliative care facilitates access to important services for the growing number of frail elderly persons who are homebound 158 and also allows patients to be cared for in their own home, as many express a preference for when asked about end-of-life care. 159 The robust evidence for this patient-centered intervention supports its continued growth in practice, with attention to adequate workforce expansion, quality assessment, and payment structure.
We found moderate-quality evidence for a few key palliative care interventions. There was moderatequality evidence for the use of music and art therapies to improve anxiety and depression in patients with advanced illness. There has been growing interest in the use of complementary therapies at the end of life; data from a 2007 National Home and Hospice Care Survey showed that over 40% of hospice care providers offered these types of therapies and about 25% of patients received some form of complementary therapy. 160 Music therapy was among the most commonly available therapies. Future research in this area will benefit from more rigorous and consistent methods to establish a high-quality evidence base and usefully guide clinical practice; trials should adequately characterize intervention characteristics, use well-validated assessments to measure symptom outcomes, and consider important mediating factors. 94 We also found moderate-quality evidence that ethics consultation improves decision-making consensus in the ICU and leads to decreased use of high-intensity and often futile life-sustaining treatments at the end of life in the ICU. The evidence suggests it may be beneficial to continue to use ethics consults to support the difficult decision-making process common to the ICU at the end of life and facilitate consensus. However, more research examining the effect of ethics consultation on outcomes such as family satisfaction and resource use (e.g., length of stay; use of LSTs) and identifying the specific components of the consult that is beneficial (e.g., communication, team coordination, ethical analysis) is warranted. 161 In addition, improved partnership and coordination between the palliative care and ethics teams in clinical practice while communicating with patients and families may further support decisional certainty and consensus.
One key area with a moderate level of evidence is interdisciplinary team care. Findings across reviews consistently demonstrate that interdisciplinary care leads to positive outcomes related to quality of life, ACP, death at home, and patient/family satisfaction with care, though confidence is tempered by some study limitations and the absence of pooled effect estimates. Interdisciplinary team care is a central and unique aspect of palliative care delivery, which relies on the contributions of multiple disciplines to provide holistic, patient-centered services at the end of life. Despite the challenges associated with team care in practice, the evidence base indicates the need to prioritize and adequately resource interdisciplinary palliative care teams in practice.
Although important individual trials have demonstrated the beneficial impact of early/integrated palliative care in certain subpopulations such as patients with advanced cancer, 4,6,162 we found low-quality evidence overall for early palliative care and outcomes such as quality of life and physical symptoms and very low-quality evidence for psychological health and mortality. The downgraded confidence reflects the variability in study designs as well as the variability in findings across studies, with different populations and the limited availability of pooled effect estimates to make strong conclusions about the impact of early palliative care broadly. Still, promising results from these trials underscore the need to continue to investigate this area across populations and settings, to build the evidence base for a practice that has significant face validity and growing empirical support.
There are several areas with low-or very low-quality evidence where reviews show promising results, but confidence in the evidence base is limited by the lack of consistently structured studies with consistent outcomes. For example, grief and bereavement interventions evaluated in the systematic reviews included in this review showed wide variation in how these services are resourced and delivered across the health system, limiting the ability to make conclusions about their effectiveness. There are also some domains where there is simply a lack of evidence, underscoring the need to expand the palliative care research base. For example, there is little evidence regarding culturally sensitive palliative care, despite the importance of acknowledging and incorporating sociocultural norms and practices in end-of-life care. There were only two systematic reviews addressing the unique needs of patients in the last days of life, and these were focused on pharmacological interventions. Owing to the tenuous clinical condition and difficult emotional time for patients and their caregivers, it remains a challenge to our field to be able to practically recruit and retain patients at the end of life for studies that can inform clinical practice.
Our review has some limitations. Because our intent was to inform the fourth edition of the NCP clinical practice guidelines for palliative care, we limited our search to systematic reviews published since 2013, when the last edition of the guidelines was published. It is possible that we may have overlooked important evidence that was published before 2013 and that has not been replicated since. Furthermore, to support all domains of the guideline, we restricted our review to systematic reviews rather than primary studies which limited our analyses. Still, systematic reviews typically represent the best available evidence as they search multiple sources with robust and comprehensive search strategies, appraise the risk of bias of individual studies, assess the study results independently from the original study authors, and aggregate research results across all available studies. It is noteworthy though that despite a large number of systematic reviews, the primary research literature can be small and the number of systematic reviews is often not an indicator for the strength of the palliative care research evidence base. Our review was guided by 10 key review questions selected with the input of our technical expert panel and mapped to the eight domains of palliative care addressed by the NCP guidelines; there may be other key palliative care evidence not identified through these key questions and thus not represented in this synthesis. We did not assess or stratify the evidence by individual interventions or conditions but instead grouped like interventions and combined advanced illness populations, which may mask important differences in the evidence. Overall, the conclusions of our review are limited by the amount and quality of available evidence. This review does not make any recommendations or state any implications for practice that go beyond an objective presentation of the evidence.
Conclusions
This systematic review highlights the large and varied body of research that exists in palliative care. Most promising areas in terms of structure and process of care are home-based palliative care, interdisciplinary team care, and telehealth approaches. There is documented evidence for comprehensive palliative care and music/art therapy addressing physical and psychological aspects of care. The existing evidence base for social needs assessments and culturally sensitive care remains very limited. There is documented evidence for life review/dignity therapy in the area of spiritual assessment approaches. Grief/ bereavement support services appear to improve key outcomes for caregivers, but the evidence base for effective approaches for care in the last days of life is very limited. Evidence for ethics consults and advance directive/physician order interventions show the strongest evidence in the ethical and legal aspects of care domain. This comprehensive review underscores the importance of targeting future research toward building high-quality evidence in key areas of clinical practice and patient/caregiver needs.
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